Anemia – an independent risk factor of adverse cardiovascular outcomes in women
Anemia, more prevalent in women than in men, is an independent predictor of cardiovascular disease (CVD) adverse outcomes. Principal methods for anemia correction in CVD patients are discussed; benefits and disadvantages of various therapeutic strategies are considered.
Main Authors: | S. N. Tereshchenko, I. V. Zhirov, T. M. Uskach |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1800 |
Similar Items
-
Erythropoietin: a new perspective in cardiovascular therapy
by: Riccardo Raddino, et al.
Published: (2016-01-01) -
A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia
by: Akira Sezai, et al.
Published: (2023-03-01) -
EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY
by: V. M. Provotorov, et al.
Published: (2016-01-01) -
APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01) -
Erythropoietin in Cardiorenal Anemia Syndrome
by: Emir Fazlibegović, et al.
Published: (2008-11-01)